THE DIGITAL SLT AND YAG PLATFORM

FROM THE INVENTORS OF SLT.
THE FUTURE OF
SLT YAG COMBINATION
STARTS HERE
LASER THERAPY INNOVATION BEGINS WITH LUMENIS
SEE YOUR PATIENTS
CLEARLY

A FULLY DIGITAL
CLINICAL WORKFLOW


HEADS UP DISPLAY.
TOTAL FOCUS.


OPTIMIZED VISUALIZATION DURING TREATMENT
DESIGNED AROUND THE
DOCTOR AND THE PATIENT
Digital Duet combines compact design, mobility, and accessibility to support modern ophthalmic practices.
- Compact all in one SLT and YAG platform, upgradeable to Digital Trio.
- ADA compliant design – Wheelchair accessible dual-motor tabletop.
- Premium, precision-engineered optics
- YAG Anterior & Posterior offset.
BACKED BY LUMENIS
CLINICAL LEADERSHIP
With decades of experience in ophthalmic laser innovation and participation in landmark studies such as LiGHT, Lumenis continues to define the standard for SLT/YAG treatment.
EXPERIENCE DIGITAL DUET
UPGRADE YOUR VISUALIZATION.
STREAMLINE YOUR WORKFLOW.
DELIVER CONFIDENT LASER FOR GLAUCOMA TREATMENT.
YAG Photodisruptor Mode
SLT Mode
Wavelength
1064 nm
532 nm
Energy
0.3–10 mJ per pulse, up to burst of 3 pulses
0.3–2 mJ
Pulse Duration
3 nano-seconds
3 nano-seconds
Repetition Rate
3 Hz
3 Hz
Spot Size
8 µm
400 µm
Digital Camera
High Definition
(HD) Resolution
High Definition
(HD) Resolution
Risk and warnings:
Digital Duet/Trio are intended for use by trained physicians. For all indications, use is contraindicated when media opacities interfere with clear visualization. Selective laser Trabeculoplasty is contraindicated for eyes with neovascular or angle-closure glaucoma; risks include iritis and transient IOP rise. Posterior Capsulotomy is contraindicated for eyes with extensive corneal dystrophy and chronically elevated IOP; risks include IOP rise, rupture of the hyaloid face, retinal damage, and uveitis. Iridotomy is contraindicated for eyes without pupillary block; risks include transient elevation of IOP, hyphemia, and damage to the lens/retina/choroid. Inadvertent photocoagulation with Smart532, especially close to the fovea or the optic nerve head, can cause permanent visual loss. Major retinal vessels should be avoided. For a complete list of contraindications and risks, refer to the operator manuals.
PB-00022541 Rev A